Scribe Therapeutics' shares are set to begin trading on Nasdaq, following an analysis of IPO trends by HSBC.
2 reports, 1 independent
Updated Jul 23
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Scribe Therapeutics' shares are set to begin trading on Nasdaq, following an analysis of IPO trends by HSBC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Scribe Therapeutics
genetic medicine therapeutics company from Alameda, California
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
HSBC
British multinational bank
Related events
- Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.
- Crescent Capital BDC, Inc. stock traded on the Nasdaq exchange and filings were made with the SEC on May 27, 2026.
- Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.
- SeaChange International began trading on the Nasdaq stock exchange.
- Yunhong Green CTI stock was traded on the Nasdaq exchange and filed required disclosures with the Securities and Exchange Commission on August 7, 2026.